DE000PE3D7C9/ DE000PE3D7C9 /
17/05/2024 21:50:33 | Chg.+0.040 | Bid21:59:54 | Demandez à21:59:54 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.830EUR | +5.06% | 0.830 Bid taille: 14,000 |
0.840 Ask la taille: 14,000 |
HALLIBURTON CO. DL... | 29.3651 - | 31/12/2078 | Call |
GlobeNewswire
00:11
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Altimmune, Inc. Investors to Secure Counsel Before Importa...
GlobeNewswire
00:00
ADSK Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Act...
GlobeNewswire
17/05
NCLA Tells Department of Education Its Newest Student Loan Debt Cancellation Plan Is Unlawful
GlobeNewswire
17/05
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of...
GlobeNewswire
17/05
Lincoln National Corporation investors: Please contact the Portnoy Law Firm to recover your losses; ...
GlobeNewswire
17/05
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic ...
GlobeNewswire
17/05
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
17/05
Experience the Illicit Romance of 19th-Century with B.D. Anderson's "Forbidden Desires"
GlobeNewswire
17/05
Altus Group Terminates Proposed Acquisition of Situs Group’s Commercial Real Estate Valuation Servic...
GlobeNewswire
17/05
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
17/05
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors wit...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page